BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for H Maruoka

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model.EBI
Asubio Pharma
2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.EBI
Asubio Pharma
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.EBI
Asubio Pharma
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphated-ester modifications as selective agonists of the P2Y(4) receptor.EBI
Niddk
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors.EBI
Daiichi Asubio Pharma
Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitors.EBI
Daiichi Asubio Pharma
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases